ViaDerma, Inc. Stock Other OTC

VDRM

US92555K1016

Biotechnology & Medical Research

OTC Markets Traded

ViaDerma, Inc. is a pharmaceutical company. The Company is engaged in the manufacture and sale of pharmaceutical related products in the United States of America. The Companyâ€™s lead product is a topical antibiotic, which is focused on being sold under the brand name Vitastem. The Company also has products in development in the fields: anti-aging skin care, pain management, hair-loss, and toenail fungus. Its products are based on a patent-pending delivery system technology that allows for rapid mass transfer of the pharmaceutical active ingredient across the skin and into the body to provide immediate localized therapy. The Company utilizes a specific trade secret formulation system in the manufacture of all products. The Companyâ€™s products are sold to local medical practitioners and patients in clinics primarily in the Los Angeles, California area. The Companyâ€™s subsidiary is ViaDerma, II Inc.

Employees

Sector

Biotechnology & Medical Research

More about the company

As early as today, start finding the best investment opportunities!

Market Cap	6.31M 5.53M 5.12M 4.71M 8.89M 607M 9M 61.12M 23.92M 298M 23.67M 23.16M 1.03B	P/E 2015	10.7x	P/E 2016	-3.3x
Enterprise Value	6.6M 5.79M 5.36M 4.94M 9.31M 636M 9.42M 64M 25.04M 312M 24.78M 24.25M 1.08B	EV / Sales 2015	1.5x	EV / Sales 2016	3.63x
Free-Float	99%	Yield 2015 *	-	Yield 2016	-

25-01-21	ViaDerma, Inc. Strengthens Global Expansion with New Dubai Office and Progress Towards Product Registration in India	CI
24-08-13	ViaDerma, Inc. Announces Commencement of the Registration Process in Kenya, Namibia, and Tanzania for Strategic Expansion into East and Southern Africa	CI
24-08-13	ViaDerma, Inc. Announces Shipment of 500,000 Units of its Product to Nigeria	CI
24-08-01	ViaDerma, Inc. Finalizes Distribution Agreements in Dubai	CI
23-03-16	ViaDerma, Inc. Announces FDA Registration Application Update & Brand Name for New Hair Regrowth Product	CI
23-03-08	ViaDerma Announces Intent to Launch New Minoxidil Hair Regrowth Product	CI
22-09-15	ViaDerma, Inc. Successfully Completes Quality Control Testing of Its New Vitastem Products	CI
21-10-04	ViaDerma, Inc. Set to Launch Two New and Improved Versions of Its Flagship Product, Vitastem and Vitastem Ultra	CI
21-06-24	ViaDerma, Inc. Provides Updates on Current Business Activities	CI
21-06-02	ViaDerma, Inc. Announces Expansion of Its Current Licensing Agreement	CI
21-05-13	ViaDerma, Inc. Nearing Initial Order from Large Hospital Network	CI
21-04-08	ViaDerma, Inc. Provides Revenue Guidance for the First Quarter of 2021	CI
21-01-21	ViaDerma, Inc. Completes a Licensing Agreement with a Group of Affiliate Wound Care Medical Practices Operating in Six States	CI

25-07-16	ViaDerma Announces Posting of Annual Report and Ongoing Evaluation of Public Status in Response to Market Changes	AQ
25-06-04	ViaDerma, Inc. Confirms Ongoing Operations and Commitment to Regulatory Compliance	AQ
25-01-21	ViaDerma, Inc. Strengthens Global Expansion with New Dubai Office and Progress Towards Product Registration in India	AQ
24-12-10	ViaDerma Announces Significant 2024 Achievements and International Expansion	AQ
24-10-03	ViaDerma, Inc. Reports Strong Financial Results for Q2 2024, Achieving Positive Net Income and Significant Cash Flow Growth	AQ

Add to a list 0 selected To use this feature you must be a member Log in Sign up	Change	5-day change	1-year change	3-year change	Capi.($)
VIADERMA, INC.	+5.85%	-24.07%	-	-	493K
LONZA GROUP AG	-4.86%	-7.02%	-2.59%	+11.35%	48.5B
REVOLUTION MEDICINES, INC.	+1.11%	+0.10%	+382.41%	+611.72%	38.97B
BEONE MEDICINES AG	+1.25%	+3.83%	+9.33%	+65.52%	35.43B
IQVIA HOLDINGS INC.	-0.88%	-3.59%	+6.40%	-12.61%	33.65B
CELLTRION, INC.	-0.87%	-1.56%	-1.43%	+29.16%	26.58B
ASCENDIS PHARMA A/S	-0.60%	-5.61%	-	-	16.82B
MEDPACE HOLDINGS, INC.	+0.79%	+0.70%	+11.56%	+115.83%	15.18B
EUROFINS SCIENTIFIC SE	+1.46%	+1.99%	+11.55%	+15.49%	13.89B
ICON PUBLIC LIMITED COMPANY	-0.02%	-3.83%	+2.47%	-31.79%	12.76B
Average	+0.34%	-1.21%	+52.46%	+100.58%	26.87B
Weighted average by Cap.	-0.73%	-1.28%	+69.57%	+127.25%

	2015	2016
Net sales	192K 168K 156K 143K 270K 18.47M 274K 1.86M 727K 9.05M 720K 704K 31.25M	252K 221K 205K 188K 355K 24.27M 359K 2.44M 956K 11.89M 946K 926K 41.06M
Net income	27.12K 23.77K 22.03K 20.27K 38.23K 2.61M 38.69K 263K 103K 1.28M 102K 99.62K 4.42M	-122K -107K -98.92K -91.05K -172K -11.73M -174K -1.18M -462K -5.75M -457K -447K -19.85M
Net Debt	288K 253K 234K 215K 406K 27.76M 411K 2.79M 1.09M 13.6M 1.08M 1.06M 46.97M	297K 260K 241K 222K 418K 28.58M 423K 2.88M 1.13M 14.01M 1.11M 1.09M 48.37M

ViaDerma, Inc. Stock Other OTC

Stocks

VDRM

US92555K1016

Biotechnology & Medical Research

Valuation: ViaDerma, Inc.

Latest news : ViaDerma, Inc.

Press Releases: ViaDerma, Inc.

Quotes and Performance

Managers and Directors: ViaDerma, Inc.

Other Biotechnology & Medical Research

Financials

Company Profile